Key facts
- This page summarizes Nandini Devi's Form 4 filing for IRIDEX CORP (IRIX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Jun 2021, 18:56.
Nandini Devi - 16 Jun 2021 Form 4 Insider Report for IRIDEX CORP (IRIX)
- Reporting relationship
- Director
- Issuer ticker
- IRIX
- Reported as of
- 16 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Jun 2021, 18:56:22 UTC
- Next SEC filing
- 16 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nilo De Castro, Attorney-in-Fact for Nandini Devi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Nandini Devi filed Form 4 for IRIDEX CORP (IRIX) on 21 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRIX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,420
- Change %
- Price
- $0.000000
- Shares after
- 5,420
- Date
- 16 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IRIX
transaction
Derivative
Common Stock (right to buy)
Award
- Transaction value
- $0
- Shares
- +15,000
- Change %
- Price
- $0.000000
- Shares after
- 15,000
- Date
- 16 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $7.38
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 16, 2022 or the date of the Issuer's next annual meeting of stockholders.
Footnote F2
This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule16b-3.
Footnote F3
The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on July 16, 2021 and each month thereafter.